William Sherman, MD
Orthopaedic Surgery · Baton Rouge, LANPI 1508037516
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,300 of the $29,313 with a category attached, or 69.3%. Stryker accounts for 83.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $18,379 and has fallen 75.9% since, to $4,424 in 2025.
Across 63 payments — averaging $465.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$25K
- Encore Medical, LP$5K
- Heraeus Medical, LLC.$73
- Medacta USA, Inc.$44
- Convatec Inc.$25
- Abbott$19
- plus $15 from 1 others
What the payments were for
- Consulting fees$20,30069%
- Speaking & faculty fees$1,5005%
- Travel & lodging$5,42018%
- Food & beverage$2,0937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 45 | $24,603 |
| Encore Medical, LP | 13 | $4,535 |
| Heraeus Medical, LLC. | 1 | $73 |
| Medacta USA, Inc. | 1 | $44 |
| Convatec Inc. | 1 | $25 |
| Abbott | 1 | $19 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,313 in reported general payments places this provider in the 85th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $274 |
| Tramadol Hcl | 53 | $162 |
| Ondansetron Hcl | 29 | $161 |
| Mupirocin | 21 | $144 |
| Cephalexin | 24 | $108 |
| Amoxicillin | 21 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Baton Rouge
- Christopher HarrodBaton Rouge$3M
- Jorge IsazaBaton Rouge$1.2M
- Kevin McCarthyBaton Rouge$594K
- Robert EastonBaton Rouge$394K
- Ricardo RodriguezBaton Rouge$262K
- Wame WaggenspackBaton Rouge$82K
- Shaun AccardoBaton Rouge$52K
- Kevin RicheBaton Rouge$33K
- David FerachiBaton Rouge$16K
- Vinod DasaKenner$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.